Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib

Overview of attention for article published in BMC Cancer, November 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 4,066 followers.

@AaronGoodman33 @Dr_AmerZeidan @MediHumdani @GunjanLShah @satya_yadav https://t.co/O4jgZLNDb9 This mutation is sensitive to Nilotinib I am not sure about Ponatinib https://t.co/AkBRR8gPLG

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.